For the GLP-1 generation
Don’t trade your skeleton
for a dress size.
Forty percent of weight lost on Ozempic, Mounjaro and Wegovy is lean tissue — muscle and bone. The drug empties the tank. MARROW builds the engine.
Join the waitlist for the Atrophy-Zero Cohort.
Thirty spots. First access.
The Thesis
Weight loss is a math problem. Structural integrity is an engineering problem.
The new metabolic drugs solve the first. They were never designed to solve the second. The body, given a steep enough caloric deficit and no countering signal, will break down whatever it can spare — and it will spare your skeleton last, not first.
What you lose, you do not casually replace. Bone density rebuilt in your forties is not bone density you had in your twenties. Muscle catabolised at one pound per week for six months is two years of disciplined training to restore.
You are not on a weight-loss journey.
You are on a structural one.
MARROW is a protocol — training, nutrition, sleep, recovery, measurement — engineered around a single objective: arrive at your goal weight with the chassis you came in with. Or better.
No before-and-afters. No transformations. No journeys.
Retain your muscle. Retain your bone. Retain your power.
The Atrophy-Zero Cohort
- Capacity30 members
- FormatAI-coached, clinician-overseen
- InputsBloodwork · DEXA · Wearable
- OutputsWeekly protocol. Daily check-ins.
- CommitmentTwelve weeks
- StatusWaitlist open
Pricing and onboarding details disclosed to waitlist members first.